Skip to content

Choroid plexus morphological and microstructural changes across inflammatory phenotypes in multiple sclerosis.

Jul 2026 · Multiple Sclerosis · pp. 13524585261462513 · 0 citations · 19 references
Medicine

TL;DR

CP volume was increased in both active RMS and inactive PMS and was associated with lower total and cortical brain volumes, suggesting CP volume may reflect processes beyond MS-specific pathology, including physiological factors.

Abstract

Background

Growing evidence supports choroid plexus (CP) involvement in MS pathophysiology, but phase-specific associations according to recent inflammatory activity and longitudinal dynamics remain unclear.

Objective

To characterize CP alterations in MS using volumetric and quantitative magnetic resonance imaging (MRI) and explore associations with neuroinflammation and neurodegeneration.

Methods

We analyzed cross-sectional and 2-year longitudinal data from 101 patients with active relapsing MS (RMS), 83 with inactive progressive MS (PMS), and 100 controls, with MS groups stratified by inflammatory activity within the prior year. CP volume, quantitative T1, and magnetization transfer saturation (MTsat) were assessed alongside imaging, serum, and clinical measures, with validation in a second cohort (62 active/357 inactive MS).

Results

CP volume was increased in both active RMS and inactive PMS and was associated with lower total and cortical brain volumes. Associations with brain microstructural damage were more pronounced in periventricular regions, compatible with a surface-in pattern. Similar associations were observed in controls, suggesting CP volume may reflect processes beyond MS-specific pathology, including physiological factors. Longitudinally, CP volume increased exclusively in active RMS, with faster expansion associated with thalamic atrophy. CP MTsat was associated with cortical and paramagnetic rim lesions in inactive PMS.

Conclusion

CP enlargement is consistent across MS phases. Longitudinal expansion occurs in active inflammatory disease and is associated with neurodegenerative changes.

View source

Similar papers

Review Open access Aug 2026

Choroid Plexus MRI Features and Cognitive Outcomes in Multiple Sclerosis: A Scoping Review

Standardized acquisition and segmentation, harmonized cognitive assessment, and adequately powered longitudinal studies are needed to establish their independent and predictive value for choroid plexus volume, as the evidence remains limited and methodologically heterogeneous.

Weronika Galus, Patrycja Romaniszyn-Kania, Aleksandra Urantówka et al. · 0 citations
Open access Aug 2026

Choroid plexus volume in pathology-confirmed Alzheimer's disease

These findings link CP enlargement to neuropathologically confirmed AD burden and CI, supporting further investigation of CP structure and function in AD.

Francis A Fernandes, Avyarthana Dey, Andy Ma et al. · 0 citations
Open access Aug 2026

Detection of Lipid-Mediated Diffused Pathological Changes in Multiple Sclerosis

Reduced tNOE contrast corresponded with known regional differences in myelin density and suggests sensitivity to myelin-integrity, and shows promise as a rapid biomarker for MS diagnosis.

Blake Benyard, Dushyant Kumar, Neil E. Wilson et al. · 0 citations
Open access Jul 2026

Choroid plexus enlargement is negatively associated with cognitive performance in a DTI-ALPS–dependent manner

CP enlargement is associated with glymphatic diffusion, and its relationship with cognitive performance varies across DTI-ALPS index values, suggesting that interactions between CSF regulatory systems may correlate with cognitive performance in a state-dependent manner.

N. Tan, T. Welton, Yi Jayne Tan et al. · 0 citations
Open access Aug 2026

Preserved neurovascular coupling in early multiple sclerosis is associated with reduced white matter lesion burden

Preserved PCA neurovascular function is associated with lower WM lesion burden, measured using conventional MRI, in MS patients with lower disability and better cognition, a finding that may inform risk stratification and guide future therapeutic targets.

C. Duque, J. Sargento-Freitas, Roumen Balabanov et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.